These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 15477330)
1. Current treatment of renal cell carcinoma. De Mulder PH; van Herpen CM; Mulders PA Ann Oncol; 2004; 15 Suppl 4():iv319-28. PubMed ID: 15477330 [No Abstract] [Full Text] [Related]
2. Immunotherapy in metastatic renal cell carcinoma. Rohrmann K; Staehler M; Haseke N; Bachmann A; Stief CG; Siebels M World J Urol; 2005 Jul; 23(3):196-201. PubMed ID: 15806434 [TBL] [Abstract][Full Text] [Related]
3. [Immunotherapy of renal cell carcinoma: results from current phase-III-trials]. Doehn C; Jocham D Aktuelle Urol; 2004 Apr; 35(2):121-9. PubMed ID: 15146376 [TBL] [Abstract][Full Text] [Related]
4. Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancer. Parton M; Gore M; Eisen T J Clin Oncol; 2006 Dec; 24(35):5584-92. PubMed ID: 17158544 [TBL] [Abstract][Full Text] [Related]
10. Chemo-immunotherapy in RCC: the end of a story. Escudier B Lancet; 2010 Feb; 375(9715):613-4. PubMed ID: 20171385 [No Abstract] [Full Text] [Related]
11. Phase II cytotoxic chemotherapy trials in renal cell carcinoma: 1983-1988. Yagoda A Prog Clin Biol Res; 1990; 350():227-41. PubMed ID: 2201045 [No Abstract] [Full Text] [Related]
12. Are we really making an advance in the treatment of metastatic renal cell carcinoma? Kirkali Z Eur Urol; 2006 Apr; 49(4):604-5. PubMed ID: 16481098 [No Abstract] [Full Text] [Related]
13. Cytokine therapy: a standard of care for metastatic renal cell carcinoma? Hutson TE; Quinn DI Clin Genitourin Cancer; 2005 Dec; 4(3):181-6. PubMed ID: 16425986 [TBL] [Abstract][Full Text] [Related]
14. [Systemic immunotherapy of metastatic renal cell carcinoma and long-term outcome]. Brinkmann OA; Roigas J; Hertle L Urologe A; 2002 May; 41(3):231-8. PubMed ID: 12132272 [TBL] [Abstract][Full Text] [Related]
17. Subcutaneous administration of interleukin-2 and interferon-alpha 2b in advanced renal cell carcinoma: long-term results. Locatelli MC; Facendola G; Pizzocaro G; Piva L; Pegoraro C; Pallavicini EB; Signaroldi A; Meregalli M; Lombardi F; Beretta GD; Scanzi F; Labianca R; Dallavalle G; Luporini G Cancer Detect Prev; 1999; 23(2):172-6. PubMed ID: 10101599 [TBL] [Abstract][Full Text] [Related]
18. [Cytokine therapy for metastatic renal cell carcinoma]. Eto M; Naito S Gan To Kagaku Ryoho; 2002 Oct; 29(10):1738-44. PubMed ID: 12402423 [TBL] [Abstract][Full Text] [Related]